QuestionThe performance of artificial intelligence-based medical tools for prostate MRI has yet to be evaluated on multi-centre, multi-vendor data to assess generalisability. FindingsA dedicated AI medical tool matches the performance of multidisciplinary team-supported radiologists in prostate canc …
Context.—. Standardized bone marrow reporting specifically for myelodysplastic syndromes/neoplasms (MDS) is currently lacking in the literature and much needed in practice.Objective.—. To propose a standardized…
This JAMA Insights discusses the need to fully assimilate evidence from observed and projected effects of climate change on health and invest in developing and…
Exciting Update: Rush to Crush Ca ncer has moved to a new fundraising platform for 2025! This means that if you previously participated in one…
PURPOSEHuman epidermal growth factor receptor 2 (HER2) alterations occur in many solid cancers, including non–small cell lung cancer (NSCLC). Beamion LUNG-1 (ClinicalTrials.gov identifier: NCT04886804) is…
Published in Leukemia & Lymphoma (Ahead of Print, 2025)
Myeloma Paper of the Day, March 10th, suggested by Robert Orlowski / BCMA-negative myeloma, cancer, CAR-T therapy, Guixiang Wang, Jiahuan Chen, Jianqing Mi,
MP accused of threatening party chair says dealing with leadership is like smashing his head against a brick wall
Get ready to mix a little learning with your libations at Pub Ed! The bar isn’t your typical classroom setting—but this event will have a…
Allograft rejection following solid-organ transplantation is a major cause of graft dysfunction and mortality. Current approaches to diagnosis rely on histology, which exhibits wide diagnostic…
Every day NIHR research saves lives and improves the quality of life of the public. The research we support drives improvements to our health and…
